SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-KSB
(X) Annual report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 for the fiscal year ended March 31, 2007 or
( ) Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the transition period from ______ to ________.
Commission file number 0-18052
STELAX INDUSTRIES LTD.
------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
State or other jurisdiction of incorporation or organization: British Columbia,
Canada
IRS Employer Identification No.: None
5515 Meadow Crest Drive, Dallas, Texas, 75229
------------------------------------------------------------------------------
(Address and zip code of principal executive offices)
Registrant's telephone number, including area code: (972) 233-6041
Securities registered pursuant to Section 12(b) of the Act: Common Stock, no par
value
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding twelve (12) months and (2) has been subject to such filing
requirements for the past ninety (90) days.
Yes X No
----- -----
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of the registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-KSB or any
amendment to this Form 10-KSB. [X]
Indicate by check mark whether the registrant is an accelerated filer (as
defined in Rule 12b-2 of the Act)
Yes No X
----- ---
The aggregate market value of the voting stock held by non-affiliates of the
Registrant as of March 15, 2007, was approximately $8,418,357. At March 31, 2007
there were 49,631,319 shares of common stock outstanding.
Documents Incorporated by Reference
NOT APPLICABLE
PART I
ITEM 1. BUSINESS.
Introduction
Stelax Industries Ltd. (the "Registrant" or the "Company") ceased all operations
in March 2002 when a Receiver acquired all assets of the Company's sole
operating entity, Stelax (U.K.) Limited, assets which were subsequently sold to
an affiliate of the Company which the Company does not control. It is the
Company's intention, subject to legal and financial restraints being removed, to
incorporate other business activities in the future.
The registrant was incorporated under the laws of British Columbia, Canada in
May 1987 as Zfax Image Corp, The Registrant changed its name from ZFAX Image
Corp. to its present name in May 1996.
The Registrant's principal executive offices are located at 5515 Meadow Crest
Dr., Dallas, Texas 75229, and its telephone number is (214) 987-1197. Unless
otherwise required by the context, the term "Company" as used herein shall mean
the Registrant and, where historically appropriate, the Registrant's U.K.
subsidiary, hereinafter referred to as "Stelax (U.K.)".
Until 1992 the Registrant was engaged in the development and production of a
portable facsimile machine using certain advanced facsimile technology. On March
31, 1995, the Registrant sold this business to the Zfax company president for
book value.
On November 15, 1995, the Company finalized agreements to acquire the real,
personal and intellectual property comprising the Aberneath steel mill facility,
paying cash of approximately $1,377,000 and issuing 2,925,000 shares of Common
Stock and assuming debt of approximately $1,316,000. The Registrant financed the
acquisition principally through the issuance of $600,000 in convertible notes,
which were subsequently converted, and the sale of $1,540,000 of Common Stock
and Warrants. The Aberneath Steel mill facility was located in Aberneath Wales,
and the Registrant's principal activities were conducted utilizing these assets
which were placed into its wholly-owned subsidiary, Stelax (U.K.), a corporation
organized under the laws of the United Kingdom.
In July 1996, the Registrant sold 10,800,000 shares of Common Stock, raising
$10,831,000. Approximately $1,100,000 of the proceeds was used to liquidate
outstanding mortgages on the Aberneath property. As part of this financing, the
Registrant's Common Stock began trading on the Le Nouveau Marche of the Paris
Stock Exchange.
Beginning in fiscal 1997, the Registrant commenced operations from the Aberneath
plant, principally producing stainless steel. The Registrant also began
developing the market for its Nuovinox product. In 1998, the market for
stainless steel was subject to severe pricing pressures, and the Company
determined to cease production of stainless steel while the Registrant developed
the Nuovinox market. Operating losses since 1997 essentially depleted the
Registrant's working capital.
In the first quarter of fiscal 2001, the Registrant began receiving orders for
the Nuovinox product, a product in which carbon steel is clad in stainless
steel. The Company also produced a steel abrasive product, Stelablast(TM). In
July 2000, with its assets unencumbered, the Registrant obtained financing from
Bank of America so that the Registrant could fulfill those orders. This
financing provided $5,000,000 of a term loan, $500,000 of receivable financing
and $250,000 inventory financing. Bank of America subsequently assigned this
obligation to Wells Fargo. While the Registrant made some shipments in fiscal
2001, the registrant expended resources on new mill tooling, completing a
finishing line and improving Nuovinox's metallurgical properties and product
quality.
Stelax (U.K.) commenced quantity production in the quarter ended June 30, 2001
but was unable to increase production to sufficiently large volumes to achieve
profitability or service debt.
On March 7th, 2002, Stelax (U.K.), was placed into Administrative Receivership
by Wells Fargo Bank, which held a loan note that ranked senior to all other debt
of Stelax (U.K.). Control over the assets of Stelax (U.K.) passed from Stelax
Industries to the U.K. Receiver at this point. A court judgement was
subsequently obtained against Stelax Industries Ltd. Please refer to Item 3 for
further details.
Between March 2002 and August 2003 (inclusive), the Receiver exercised complete
managerial control over the assets of Stelax (U.K.). Final delivery against one
outstanding order was made in March 2002 but since that time no production or
deliveries took place. All but one of the employees of the U.K. company was made
redundant in March 2002. During the period March 2002 and August 2003 the
Receiver was authorized to undertake the sale of the U.K. company's assets
either as a whole entity or on the basis of break up.
In June 2003 an affiliate of the Registrant Company, through an intermediary
company (Timaran Ltd.), made a contract with the Receiver to purchase all of the
Stelax (U.K.) assets held by the Receiver. Timaran Ltd. started recommissioning
-1-
and operating the Aberneath Facility. In August Timaran completed the purchase
of the U.K. assets from the Receiver. Timaran has assigned all its rights and
interest to Stelax International Ltd., a private company unassociated with
Stelax Industries Ltd. See item 12. Certain Relationships and Related
Transactions.
With the acquisition of the assets by the Receiver and subsequent purchase by an
affiliate of the Company which the Company does not control, the Company lost
all ability to produce Nuovinox, including any inventory, facilities, equipment
and intellectual property such as patents and trademarks.
In the opinion of the Company's management, interest in the Nuovinox product
remains strong. But the Registrant no longer has any direct or indirect interest
in the operations that are presently making Nuovinox.
Products
With the sale of the Company's sole operating assets by the Receiver to an
affiliate of the Company, the Company's operations ceased. Prior to the
possession of the U.K company's assets by the Receiver, the Company had been
capable of producing two distinct product lines at it's Aberneath facility: (i)
the Company's patented Nuovinox product, a stainless steel cladded product with
metallurigically joined carbon steel core and (ii) steel abrasive shot in
various sizes marketed under the name Stelablast.
Nuovinox is a carbon steel product cladded with stainless steel. From raw
stainless steel the Registrant created tubes several inches in diameter and
filled the tubes with treated scrap steel, reducing and elongating the tubes in
a proprietary process until the desired product was created, usually rebar 1/2
inch or larger in diameter with a core of carbon sheet and an outer casing of
stainless steel. The most commonly produced product was rebar, but Nuovinox
could be manufactured in flat bar, round bar and pipes of various sizes and
dimensions. The resultant product, which generally consisted of up to 25% of
stainless steel by weight, created a molecular bond between the carbon steel
core and the stainless steel exterior. The raw materials for the rebar comes
from very low grade scrap steel.
Employees
As of, March 15, 2006, the Company did not have any employees or independent
contractors working for it.
ITEM 2. PROPERTIES.
The Company's principal executive offices in the United States are located at a
private residence, 5515 Meadow Crest Dr., Dallas, TX 75229. Until acquired by a
Receiver in March 2002 the Company owned the land and buildings comprising the
Aberneath Facility in Wales, United Kingdom. See Item 1. Business.
ITEM 3. LEGAL PROCEEDINGS.
In March 2002 Stelax (U.K.) was placed into administrative receivership by a
loan creditor, Wells Fargo Business Credit, Inc. which was exercising powers and
remedies available to it by law and a Loan and Security Agreement, originally
made on June 30, 2000, with Banc of America Commercial Finance Corporation and
subsequently assigned on April 20, 2001 by Banc of America Finance Corporation
to Wells Fargo Business Credit, Inc. Simultaneously with the original execution
of the Loan and Security Agreement, Stelax Industries, Ltd., the registrant,
executed a guarantee of the Loan and Security Agreement, and the guarantee was
also assigned to Wells Fargo Business Credit, Inc.
When Stelax (U.K.) was placed into administrative receivership, all of the
registrant's operations effectively ceased. On March 5, 2002, Wells Fargo
Business Credit, Inc. filed a complaint in the United States District Court for
the Southern District of New York against Stelax Industries, Ltd., Stelax (U.K.)
and Stelax U.S.A., Inc. seeking damages because of failure to make payments
pursuant to the aforementioned agreements. On July 2, 2002 the court entered a
judgment against all three defendants, and on February 4, 2003, entered a
judgment of $4,041,778.27 plus $911.46 interest per day from August 22, 2002 to
January 31, 2003. Post judgment interest was also awarded calculated from
January 31, 2003.
As of the date hereof, this judgment has not been satisfied.
In February 2006, the second section of the Sanction Commission of the Autorite
des Marches Financiees, regulatory authorities responsible for monitoring
trading in France which obtained jurisdiction because our stock was traded on
the Nouveau Marche in France, asserted that we had failed to provide French
translations of certain documents filed with the Securities and Exchange
Commission, resulting in a penalty against us and our Chief Executive officer,
Harmon H. Hardy, of 30,000 and 10,000 Euros, respectively.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
Not applicable.
-2-
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.
Market Information
During fiscal 2007 and 2006, the Registrant's Common Stock was quoted on the
NASDAQ Bulletin Board System. It is currently quoted on the Pink Sheets. The
Registrant's Common Stock in the United States trades under the symbol "STAX".
They represent inter-dealer prices and do not represent actual transactions. The
range of the closing high and low bid and prices as quoted on the NASDAQ
Bulletin Board and Pink Sheets from April 1, 2005 through March 31, 2007 is as
follows:
Bid Ask
Fiscal 2006 High Low High Low
----------- ---- --- ---- ---
First Quarter 0.31 0.17 0.35 0.19
Second Quarter 0.22 0.18 0.25 0.19
Third Quarter 0.225 0.09 0.24 0.11
Fourth Quarter 0.24 0.13 0.27 0.13
Bid Ask
Fiscal 2007 High Low High Low
----------- ---- --- ---- ---
First Quarter 0.16 0.10 0.18 0.10
Second Quarter 0.135 0.075 0.18 0.08
Third Quarter 0.10 0.06 0.11 0.06
Fourth Quarter 0.095 0.046 0.10 0.05
The Registrant's Common Stock is also quoted on the Le Nouveau Marche of the
Paris Stock Exchange. Trading on the Le Nouveau Marche commenced July 11, 1996.
With respect to a recent sanction imposed by French regulatory authorities, see
"Item 3. Legal Proceedings."
Holders
As of March 15, 2007, there were approximately 200 holders of record of the
Registrant's Common Stock.
Dividends
The future payment by the Registrant of dividends, if any, rests within the
discretion of its Board of Directors and will depend upon the Registrant's
earnings, if any, capital requirements and the Registrant's financial condition,
as well as other relevant factors. The Registrant has not declared dividends
since its inception, and has no present intention of paying cash dividends on
its Common Stock in the foreseeable future.
-3-
Equity Compensation Plan Information
As of March 31, 2007, there were no options to purchase of common stock
outstanding but there were warrants to purchase 160,000 shares of common stock.
There are no plans to issue any new options or warrants.
Previous equity compensation plans not approved by security holders constitute
compensation for services rendered to the registrant, principally the officers
and directors (750,000 shares).
ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL PLAN OF OPERATION.
Forward-Looking Statements - Cautionary Statements. This Annual Report contains
certain "forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of
the Securities Exchange Act of 1934, as amended (the "Exchange Act").
Specifically, all statements other than statements of historical facts included
in this report regarding the Company's financial position, business strategy and
plans and objectives of management of the Company for future operations are
forward-looking statements. These forward-looking statements are based on the
beliefs of the Company's management, as well as assumptions made by and
information currently available to the Company's management. When used in this
report, the words "anticipate," "believe," "estimate," "expect," and "intend"
and words or phrases of similar import, as they relate to the Company or Company
management, are intended to identify forward-looking statements. Such statements
reflect the current view of the Company with respect to future events and are
subject to risks, uncertainties and assumptions related to various factors
including, without limitation, competitive factors, general economic conditions,
customer relations, increases in raw material prices, governmental regulation
and supervision, seasonality, acceptance of the Company's Nuovinox products in
the marketplace, technological changes and changes in industry practices
("cautionary statements"). Although the Company believes that its expectations
are reasonable, it can give no assurance that such expectations will prove to be
correct. Based upon changing conditions, should any one or more of these risks
or uncertainties materialize, or should any underlying assumptions prove
incorrect, actual results may vary materially from those described herein as
anticipated, believed, estimated, expected or intended. All subsequent written
and oral forward-looking statements attributable to the Company or persons
acting on its behalf are expressly qualified in their entirety by the applicable
cautionary statements.
Liquidity and Capital Resources
With the Company's cessation of operations because of the receivership in March
2002 of Stelax (U.K.) and subsequent judgment against Stelax Industries Ltd,
Stelax (U.K.)'s parent, the Company lacked any resources to conduct operations
or to pay its creditors.
In fiscal year 2007, there was no commercial activity within the Company. The
Company consumed $80 cash. Cash used by operating activities amounted to $80.
There were no purchases of property, equipment or intangibles in this period and
no cash payment in regard to interest within the year. The resulting year end
cash and equivalents balance was $21. Certain expenses relating to regulatory
matters of the Corporation were advanced by its affiliates.
At the present time the Company possesses no operational activities and lacks
cash resources to either service or repay its debt. Debt forgiveness from its
major creditor, Wells Fargo Inc. would allow the Company to reverse this
position. Liquidation of the Company is not imminent and therefore the Directors
have concluded that it is appropriate to prepare the financial statements on a
going concern basis. The Company's audit report is modified because of this
concern. The Directors of the Company do not believe that any material
adjustments to the values of assets or liabilities would be necessary to reflect
the "liquidation basis".
2007 compared to 2006
Because the Company had no operations, the Company had no revenues in fiscal
2007 or 2006 and in fiscal 2006 incurred a loss of $276,904, $54,926 of which
related to professional fees required for regulatory matters. In fiscal 2006 our
loss was $374,541, $42,026 of which was compensation for stock issued and
$41,846 was for legal and accounting fees. The balance was for interest expense
accrued on the judgment on the Wells Fargo note.
Accounting Policies
The Company's accounting policies are detailed in Note 1 to the Consolidated
Financial Statements. The Company follows US GAAP. In applying these accounting
policies in the preparation of the consolidated financial statements, management
is required to make estimates and assumptions about future events that affect
the reporting and disclosure of assets and liabilities at the balance sheet
dates and the reported amounts of revenue and expense during the periods
covered. In view of the fact that the Company currently has no operations
management do not believe that it has any critical accounting policies which are
impacted by judgments and uncertainties and for which different amounts would be
reported under a different set of conditions or using different assumptions.
-4-
RECENTLY ISSUED BUT NOT YET ADOPTED ACCOUNTING STANDARDS
In view of the fact that the Company has no operations no recently issued but
not yet adopted accounting pronouncements are expected to have a material impact
on the Company's results of operations or financial position.
ITEM 7. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
See the consolidated financial statements beginning at page F-2 of this Form
10-KSB Annual Report.
ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE.
Not applicable.
ITEM 8A. CONTROLS AND PROCEDURES.
Annual Evaluation of Our Disclosure Controls and Internal Controls
Within the 90 days prior to the date of this Annual Report on Form 10-KSB,
management evaluated the effectiveness of the design and operation of the
Company's disclosure controls and procedures and the internal controls and
procedures for financial reporting. This controls evaluation was done under the
supervision and with the participation of the Chief Executive Officer (CEO) and
Chief Financial Officer (CFO), both offices being performed by Harmon H. Hardy.
Following are the conclusions of Mr. Hardy, acting as the Company's CEO and the
CFO, with respect to the effectiveness of our disclosure controls and internal
controls as of March 15, 2007.
CEO and CFO Certifications
Appearing immediately following the Signatures section of this Annual Report on
Form 10-KSB there are certifications of the CEO and the CFO. The certifications
are required in accordance with Section 302 of the Sarbanes-Oxley Act of 2002.
This section of the Annual Report is the information concerning the controls
evaluation referred to in the Section 302 certifications and this information
should be read in conjunction with the Section 302 certifications for a more
complete understanding of the topics presented.
Disclosure Controls and Internal Controls
Disclosure controls are procedures that are designed with the objective of
ensuring that information required to be disclosed in reports filed under the
Securities Exchange Act of 1934, or the Exchange Act, such as this Annual
Report, is recorded, processed, summarized and reported within the time periods
specified in the SEC's rules and forms. Disclosure controls are also designed
with the objective of ensuring that such information is accumulated and
communicated to management, including the CEO and CFO, as appropriate to allow
timely decisions regarding required disclosure. Internal controls are procedures
which are designed with the objective of providing reasonable assurance that the
Company's transactions are properly authorized, its assets are safeguarded
against unauthorized or improper use and transactions are properly recorded and
reported, all to permit the preparation of the Company's financial statements in
conformity with generally accepted accounting principles.
Scope of the Controls Evaluation
The evaluation of our disclosure controls and our internal controls by our CEO
and our CFO included a review of all previously existing controls as well as
those recently implemented by the Company and the effect of the controls on the
information generated for use in this Annual Report on Form 10-KSB. In the
course of the controls evaluation, management sought to identify data errors,
controls problems or acts of fraud and to confirm that appropriate corrective
action, including process improvements, were being undertaken. The internal
controls are also evaluated on an ongoing basis by the Company's independent
auditors in connection with their audit and review activities. The overall goals
of these various evaluation activities are to monitor the Company's disclosure
controls and internal controls and to make modifications as necessary, with the
intent being that the disclosure controls and the internal controls will be
maintained as dynamic systems that change (including with improvements and
corrections) as conditions warrant. Among other matters, management sought in
its evaluation to determine whether there were any "significant deficiencies" or
"material weaknesses" in the Company's internal controls, or whether any acts of
fraud involving personnel who have a significant role in the internal controls
were identified. This information was important both for the controls evaluation
generally and because Items 5 and 6 in the Section 302 certifications of the CEO
and the CFO require that the CEO and the CFO disclose such information to the
Company's Board of Directors, which acts as the Company's Audit Committee, and
to the independent auditors and to report on related matters in this section of
the Annual Report on Form 10-KSB. In the professional auditing literature,
-5-
"significant deficiencies" are referred to as "reportable conditions." These are
control issues that could have a significant adverse effect on the ability to
record, process, summarize and report financial data in the financial
statements. A "material weakness" is defined in the auditing literature as a
particularly serious reportable condition where the internal control does not
reduce to a relatively low level the risk that misstatements caused by error or
fraud may occur in amounts that would be material in relation to the financial
statements and not be detected within a timely period by employees in the normal
course of performing their assigned functions. Management also sought to deal
with other controls matters in the controls evaluation and, in each case if a
problem was identified, to consider what revision, improvement and/or correction
to make in accordance with ongoing procedures.
Conclusions
Based upon the controls evaluation, Mr. Hardy, acting as the Company's CEO and
CFO has concluded that the Company's disclosure controls are effective to ensure
that material information relating to the Company is made known to management
particularly during the period when the Company's periodic reports are being
prepared, and that the Company's internal controls are effective to provide
reasonable assurance that the Company's financial statements are fairly
presented in conformity with generally accepted accounting principles. Further,
since the date of the controls evaluation to the date of this Annual Report,
there have been no significant changes in internal controls or in other factors
that could significantly affect internal controls, including any corrective
actions with regard to significant deficiencies and material weaknesses.
ITEM 8B. OTHER INFORMATION.
Not applicable
-6-
PART III
ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS' COMPLIANCE
WITH SECTION 16(a) OF THE EXCHANGE ACT.
Directors and Officers
Directors and executive officers are elected to serve until each's respective
successor is elected and qualified, typically at the next ensuing annual meeting
of stockholders. The directors and executive officers of the Company as of March
31, 2006 are as follows:
Name and Age Position Served In Office Since
Harmon S. Hardy, 77 Chairman of the 1987
Board, President
and Chief Financial Officer
Harmon S. Hardy has been the President of the Company since its inception in
May, 1987 and is Chairman and President of various other entities. Mr. Hardy
devotes a substantial portion of his time to the matters and business of the
Company. . With respect to a sanction imposed against Mr. Hardy by French
regulatory authorities, see Item 3. Certain Legal Proceedings
Audit Committee
The Company does not have an audit committee.
Compliance with Section 16(a) of the Securities Exchange Act of 1934
Section 16(a) of the Securities Exchange Act of 1934 requires the Company's
officers and directors, and persons who own more than 10% of a registered class
of the Company's equity securities, to file reports of ownership and changes in
ownership with the Securities and Exchange Commission. Officers, directors and
10% stockholders are required by regulations promulgated by the Securities and
Exchange Commission to furnish the Company copies of all Section 16(a) reports
they file.
The Company believes all Section 16(a) filing requirements applicable to its
officers, directors and 10% beneficial owners were complied with through March
31, 2007.
Code of Ethics
Given that the Company no longer has operations, the Company has not adopted a
Code of Ethics for the principal executive officer, principal financial officer,
or principal accounting officer or controller.
-7-
ITEM 10. EXECUTIVE COMPENSATION
The following table sets forth information with respect to the compensation to
the Company's chief executive officer at March 31, 2007 for services rendered
during the fiscal years ended March 31, 2007, 2006, and 2005. The table includes
for the same periods those individuals receiving in excess of $100,000 per year.
Annual Compensation (1)
Stock All Other
Options Compensa-
Name Year Salary Bonus Other (Shares) tion
------------------------- --------- ------------ ------------- ----------- ------------ ------------
Harmon S. Hardy 2007 $ - $ - $ - - $ -
Chairman of the 2006 $ - $ - $ - - $ -
Board of Directors 2005 $ - $ - $ - - $ -
President and Chief
Financial Officer
(1) No executive officer named above received other compensation in excess
of the lesser of $50,000 or 10% of such officer's salary and bonus
compensation.
(2) Includes a monthly car allowance which has been accrued but not paid.
See Item 12. Certain Relationships and Related Transactions.
-8-
ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth, as of March 31, 2007, the number and percentage
of outstanding shares of Common Stock beneficially owned by (i) each person
known by the Company to be a beneficial owner of more than five percent (5%) of
the Company's Common Stock; (ii) each of the executive officers of the Company;
(iii) each director of the Company; and (iv) all officers and other directors as
a group:
Shares of Common
Stock Beneficially Percentage
Name and Address of Beneficial Owner (1) Owned of Class
--------------------------------------------------- -------------------------- ----------------
Harmon S. Hardy, Jr. 12,366,061 24.9%
4004 Belt Line Road, Suite 107
Dallas, TX 75244
All Officers and other Directors as a Group 12,366,061 24.9%
(1) The persons named in the table have sole voting and investment power with
respect to all shares of Common Stock showing as beneficially owned by them,
subject to community property laws, where applicable, and the information
contained in the footnotes to the table.
ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
In August 2003 an entity owned by Harmon H. Hardy acquired for $900,000 the
manufacturing facility, intellectual property and real property, the
registrant's operating assets prior to acquisition by the receiver, from a
receiver who had acquired all of those assets in March 2002 from Stelax (UK)
Limited, a subsidiary of the registrant. See Item 1 - Business and Item 4 -
Legal Proceedings.
As of March 31, 2007 and 2006, funds were due to the President and his
affiliates totaling $508,625 and $413,852, respectively. These amounts are
payable on demand. See Note 2 Notes to Financial Statements.
ITEM 13. EXHIBITS
(a) See "Index to Consolidated Financial Statements" included at F-1 of this
Form 10-KSB Annual Report for a listing of financial statements and schedules
filed as a part of this Form 10-KSB Annual Report.
(b) The following exhibits are or have been filed as a part of this Annual
Report on Form 10-KSB:
Exhibit
Number Description of Exhibit Location of Exhibit
3(a) Certificate of Incorporation of the Company a
3(b) Memorandum of Association of the Company a
3(c) Articles of the Company a
3(d) Amendment to Articles of the Company a
3(e) Amendment to Articles of the Company
changing the name to "Stelax Industries Ltd."
Previously filed
4(a) Form of Stock Certificate a
4(b) Form of 7% Convertible Note due August 31, 1997 c
4(c) Form of Common Stock Purchase Warrant b
-9-
10(a) Sale and Purchase Agreement dated August 4, 1995 by and
between Shipyard Limited and ZX(U.K.) Limited
(c/k/a Stelax (U.K.) Limited) b
10(b) Agreement for Sale and Purchase of Assets by and between
Camborne Industries PLC (in receivership) and ZX(U.K.) Limited
(c/k/a Stelax (U.K.) Limited) b
10(c) Agreement relating to the land and buildings at Wern Works,
Briton Ferry Neath by and between Maritime Transport
Services Limited and ZX(U.K.) Limited (c/k/a Stelax (U.K.)
Limited) b
10(d) Variation Agreement dated November 13, 1995 by and between
Camborne Industries PLC and ZX(U.K.) Limited (c/k/a Stelax (U.K.)
Limited) b
10(e) Agreement dated November 13, 1995 by and between
Maritime Transport Services Limited and ZX(U.K.) Limited
(c/k/a Stelax (U.K.) Limited) b
10(f) Chattel Mortgage dated November 13, 1995 by and between
ZX(U.K.) Limited and Camborne Industries PLC (c/k/a Stelax
(U.K.) Limited) b
10(g) Patent Mortgage dated November 13, 1995 by and
between ZX(U.K.) Limited and Camborne Industries PLC (c/k/a
Stelax (U.K.) Limited) b
10(h) Trademarks Mortgage dated November 13, 1995 by and between
ZX(U.K.) Limited and Camborne Industries PLC (c/k/a Stelax
(U.K.) Limited) b
21(a) Subsidiaries of the Company
Stelax (U.K.) Limited, a United Kingdom subsidiary
Stelax USA, Inc., a Delaware corporation
31* Certification of the Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
32* Certification of the Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
*Filed herewith
a. Incorporated by reference from the Form S-18 Registration
Statement, as amended (No. 33-27667-FW), for the Company.
b. Incorporated by reference from the Form 8-K dated November 7,
1995.
(c) Reports on Form 8-K.
No reports on Form 8-K were filed during the last fiscal
quarter of 2004.
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
The aggregate fees billed by Killman, Murrell & Company, P.C. rendered for the
audit of the Company's annual financial statements for the year ended March 31,
2007 and the reviews of the financial statements included in the Company's Forms
10-Q through December 31, 2006 were $30,485 compared to $22,308 for 2006.
-10-
STELAX INDUSTRIES LTD
TABLE OF CONTENTS
Page
Report of Independent Registered Public Accounting Firm
Killman, Murrell & Company, P.C. F-2
Consolidated Financial Statements
Consolidated Balance Sheets as of March 31, 2007 and 2006 F-3
Consolidated Statements of Operations for the Years Ended March 31, 2007 and 2006 F-4
Consolidated Statements of Stockholders' Deficit for the Years Ended March 31, 2007 and 2006 F-5
Consolidated Statements of Cash Flows for the Years Ended March 31, 2007 and 2006 F-6
Notes to Consolidated Financial Statements F-7
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Stelax Industries Ltd
British Columbia, Canada
We have audited the accompanying consolidated balance sheets of Stelax
Industries Ltd. and Subsidiary as of March 31, 2007 and 2006, and the related
consolidated statements of operations, stockholders' (deficit), and cash flows
for the years then ended. These consolidated financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these consolidated financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. The company is not required to
have, nor were we engaged to perform, an audit of its internal control over
financial reporting. Our audit included consideration of internal control over
financial reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the company's internal control over financial
reporting. Accordingly, we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of Stelax
Industries Ltd. and Subsidiary as of March 31, 2007 and 2006, and the
consolidated results of their operations and their cash flows for the years then
ended in conformity with United States generally accepted accounting principles.
The accompanying consolidated financial statements have been prepared assuming
the Company will continue as a going concern. As discussed in Note 6 to the
consolidated financial statements, the Company has suffered recurring losses
from operations and its limited capital resources raise substantial doubt about
its ability to continue as a going concern. Management's plans in regard to
these matters are described in Note 6. The consolidated financial statements do
not include any adjustments that might result from the outcome of this
uncertainty.
/s/ Killman, Murrell & Company, P.C.
KILLMAN, MURRELL & COMPANY, P.C.
Odessa, Texas
July 9, 2007
F-2
STELAX INDUSTRIES LTD and SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
MARCH 31, 2007 AND 2006
(Presented in United States dollars)
ASSETS
March 31,
-----------------------------------
2007 2006
------------- -------------
CURRENT ASSETS
Cash and cash equivalents $ - $ 21
------------- -------------
Total Current Assets - 21
------------- -------------
TOTAL ASSETS $ - $ 21
============= =============
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable $ 366,727 $ 406,474
Payable torelated parties 508,625 413,852
Accrued interest 2,095,888 1,764,058
Other accrued liabilities 122,113 122,113
Note payable 3,645,833 3,645,833
------------- -------------
TOTAL CURRENT LIABILITIES 6,739,186 6,352,330
------------- -------------
STOCKHOLDERS' DEFICIT
Common stock - 50,000,000 shares
Authorized, no stated par value;
Issued and outstanding 49,631,319 shares 26,750,090 26,750,090
Additional paid-in capital 477,060 477,060
Accumulated deficit (33,966,336) (33,579,459)
------------- -------------
TOTAL STOCKHOLDERS' DEFICIT (6,739,186) (6,352,309)
------------- -------------
TOTAL LIABILITIES AND
STOCKHOLDERS' DEFICIT $ - $ 21
============= =============
The accompanying notes are an
Integral part of these consolidated financial statement
F-3
STELAX INDUSTRIES LTD and SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED MARCH 31, 2007 AND 2006
(Presented in United States dollars)
Years Ended March 31,
---------------------------------------------
2007 2006
-------------- -------------
SELLING, GENERAL &
ADMINISTRATIVE EXPENSES $ 55,047 $ 76,026
------------ -------------
LOSS FROM OPERATIONS (55,047) (76,026)
OTHER (EXPENSE)
Interest expense (331,830) (332,515)
------------ ------------
NET LOSS $ (386,877) $ (408,541)
============ =============
Weighted Average Shares of Common
Stock - Basic and Diluted 49,631,319 49,631,319
============ =============
NET LOSS PER SHARE
Basic and Diluted $ (0.00) $ (0.00)
============ =============
The accompanying notes are an
Integral part of these consolidated financial statement
F-4
STELAX INDUSTRIES LTD and SUBSIDIARY
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
FOR THE YEARS ENDED MARCH 31, 2007 AND 2006
(Presented in United States dollars)
Additional
Common Stock Paid-in Accumulated
Shares Amount Capital Deficit Total
------------- ------------ ------- ------------- ----------
BALANCE at March 31, 2005 49,631,319 $ 26,750,090 $ 477,060 $ (33,170,918) $(5,943,768)
Net Loss - - - (408,541) (408,541)
------------ ------------ ------- ------------ ----------
BALANCE at March 31, 2006 49,631,319 26,750,090 477,060 (33,579,459) (6,352,309)
----------- ------------ -------- ------------- ----------
Net Loss - - - (386,877) (386,877)
----------- ----------- -------- ------------- ----------
BALANCE at March 31, 2007 49,631,319 $ 26,750,090 $ 477,060 $ (33,966,336) $(6,739,186)
=========== ============ ========= ============== ==========
The accompanying notes are an
Integral part of these consolidated financial statement
F-5
STELAX INDUSTRIES LTD and SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED MARCH 31, 2007 AND 2006
(Presented in United States dollars)
Years Ended March 31,
-----------------------------------------
2007 2006
------------- -------------
CASH FLOW FROM OPERATING ACTIVITIES
Net Loss $ (386,877) $ (408,541)
Changes in Operating Assets and Liabilities
Accounts Payable and Accruals 292,083 372,772
Payable to Related Parties 94,773 35,689
----------- -----------
NET CASH USED BY
OPERATING ACTIVITIES (21) (80)
----------- -----------
NET (DECREASE) IN CASH AND
CASH EQUIVALENTS (21) (80)
CASH AND CASH EQUIVALENTS
AT BEGINNING OF YEAR 21 101
----------- -----------
CASH AND CASH EQUIVALENTS
AT END OF YEAR $ - $ 21
=========== ============
SUPPLEMENTAL DISCLOSURE OF
CASH FLOW INFORMATION
Interest Paid $ - $ -
=========== ============
Income Taxes Paid $ - $ -
=========== ============
The accompanying notes are an
Integral part of these consolidated financial statement
F-6
STELAX INDUSTRIES LTD
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Presented in United States dollars)
MARCH 31, 2007 AND 2006
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization
Stelax Industries Ltd. (a Canadian corporation) formerly Zfax Image Corp., (the
"Company") was incorporated on May 5, 1987, primarily to develop and produce
portable facsimile machines. These operations were conducted through the
Company's formerly owned subsidiary, Zfax, Inc.
On July 11, 1995, the Company incorporated Stelax (U.K.) Limited ("Stelax") as a
wholly owned subsidiary in the United Kingdom to acquire certain assets of a
steel mill in West Glamorgan, Wales and establish operations in the stainless
steel manufacturing business. The steel mill ceased operations in March 2002.
The steel mill and all of the subsidiary's other operating assets were forfeited
to the Company's secured creditor on March 7, 2002. All significant intercompany
balances and transactions have been eliminated in consolidation.
The Company's consolidated financial statements are presented in accordance with
accounting principles generally accepted in the United States of America (US
GAAP). The financial statements have been prepared on the basis that the company
is a "going concern". In the absence of any debt forgiveness from Wells Fargo,
the Company can not pay its debts and is not a "going concern". However the
Directors of the Company do not believe that any material adjustments to the
values of assets or liabilities would be necessary to reflect the "liquidation
basis" and believe that the Company can become a going concern again in the
future but hinges this opinion on the willingness of the loan creditor, Wells
Fargo, to grant debt forgiveness. It would become a going concern by
incorporating other business activities into the group. The Company is in
default of covenants and repayment schedules on the Term Loan, Revolving Credit
and Credit Accommodations with Wells Fargo Business Credit, Inc. As a result of
these defaults, on March 7, 2002, Wells Fargo appointed an administrative
receiver to the subsidiary under the terms of the debenture instrument to manage
the assets covered by the note payable agreement. The group's operations
therefore ceased from this point. On January 31, 2003, the United States
District Court for the Southern District of New York entered an Order of
Judgment in favor of Wells Fargo Business Credit, Inc. against Stelax
Industries, Ltd., Stelax (U.K.), and Stelax Industries in the amount of
$4,041,778.27 plus $911.46 per day for each day from August 22, 2002 until the
entry of the judgment which occurred on January 31, 2003. In the Order of
Judgment, the judge adopted the magistrate's recommendations. The magistrate's
recommendations indicated that the plaintiff filed a complaint against the
defendants on March 5, 2002. On June 13, 2002, the Court's clerk issued a
Certificate of Default and on July 2, 2002, the court entered the default
judgment, referring the matter to the magistrate to determine damages. In August
2003 Timaran Limited purchased the assets of the U.K. company from the Receiver.
Timaran Limited has assigned all its rights and interest in these assets to
Stelax International Ltd., a private company unassociated with Stelax Industries
Ltd. The judgment against Stelax Industries Ltd. still remains.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of
three months or less when purchased to be cash equivalents.
Loss Per Share
Losses per share have been computed in accordance with SFAS No. 128, Earnings
per Share. Basic and diluted losses per share are computed by dividing net loss
by the weighted average number of shares of Common Stock outstanding during the
year. Outstanding Common Stock options and warrants have been excluded from the
calculation of diluted losses per share because their effect would be
antidilutive. The number of share options outstanding at March 31, 2007 and 2006
that could be potentially dilutive was zero for both years. In addition, the
number of warrants outstanding at March 31, 2007 and 2006 and that could be
potentially dilutive was 160,000.
(Continued)
F-7
STELAX INDUSTRIES LTD
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Presented in United States dollars)
MARCH 31, 2007 AND 2006
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Use of Estimates
The preparation of the consolidated financial statements in conformity with US
generally accepted accounting principles requires management to make estimates
and assumptions that affect the amounts reported in the financial statements and
accompanying notes. Actual results could differ from those estimates.
Warrants
The proceeds received upon issuance of debt and detachable warrants are
allocated between the debt and the warrants on a relative fair value basis. The
fair value of the warrants is determined with reference to a Black-Scholes
valuation model. Any resulting debt discount is amortized over the term of the
debt using the effective interest rate method.
The fair value of warrants issued in connection with the grant of a line of
credit is deferred and recognized in the income statement on a straight-line
basis over the period under which the credit facility is available. When amounts
are drawn down, the unamortized deferred warrant cost is allocated, on a
pro-rate basis, between the draw down amount and the remaining available credit
facility. The portion allocated to the draw down amount is recognized over the
period of the loan using the effective interest rate method.
Income Taxes
The Company uses the liability method of accounting for income taxes in
accordance with SFAS No. 109, "Accounting for Income Taxes." Under the liability
method, deferred income taxes are determined based upon enacted tax laws and
rates applied to the difference between the financial statement and tax bases of
assets and liabilities.
Foreign Currency Translation
In accordance with the provisions of SFAS No. 52, "Foreign Currency
Translation," exchange adjustments resulting from foreign currency transactions
generally are recognized currently in income, whereas adjustments resulting from
translations of financial statements are reflected in accumulated other
comprehensive income (loss). The cumulative currency translation loss as of
March 31, 2007 and 2006 was $nil.
Financial Instruments
The fair values of financial instruments are determined by reference to various
market data and other valuation techniques, as appropriate. Unless otherwise
disclosed, the fair values of financial instruments approximate their recorded
values.
F-8
STELAX INDUSTRIES LTD
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Presented in United States dollars)
MARCH 31, 2007 AND 2006
NOTE 2: RELATED PARTY TRANSACTIONS
As of March 31, 2007 and 2006, funds were due to the President and his
affiliates totaling $508,625 and $413,852, respectively. These amounts are
payable on demand. Effective January 12, 1999, the President of the Company
began providing a line of credit up to $600,000 for the benefit of the Company.
The credit line bears interest at 10% and 600,000 warrants to purchase Common
Stock of the Company at $.30 per share were issued as consideration for such
credit line. In fiscal year 2000, the line of credit was extended to $1,200,000
at the same interest rate. An additional 600,000 warrants were issued at $.50 a
share. The warrants are valid for five (5) years. The fair value calculated
using the Black-Scholes option valuation model was $353,984 and as such
additional paid in capital and pre-paid interest has been recognized.
NOTE 3: OPTIONS
The Company has granted stock options to certain directors, officers, investors
and consultants to purchase shares of the Company's common stock under a
non-qualified plan. No new options were issued in fiscal years 2007 or 2006;
however, the outstanding 550,000 options expired during the fiscal year ending
March 31, 2006.
Using the Black-Scholes valuation method, the fair value of the options granted
was zero. The fair value of the options granted has been estimated assuming no
dividends and using the following assumptions:
Risk Free Interest Rate 4.5%
Expected Term 10 Months
Volatility 61.8%
Weighed Average Fair Value Per Share
for Options Granted During the Year $ 0.85
A summary of the stock option transactions follows:
WEIGHTED
AVERAGE
NUMBER EXERCISE PRICE EXERCISE PRICE
OF SHARES PER SHARE PER SHARE
--------- -------------------- -------------
Options outstanding March 31, 2003 8,940,000 $ 0.551
Issued 40,000 $ 0.85 $ 0.850
Expired (3,265,000)
---------
Options outstanding March 31, 2004 5,000,000 $ 0.537
Expired (4,500,000) $ 0.537
---------
Options outstanding March 31, 2005 550,000
Expired (550,000) $ 0
-------
Options outstanding March 31, 2006 0
=======
(Continued)
F-9
STELAX INDUSTRIES LTD
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Presented in United States dollars)
MARCH 31, 2007 AND 2006
NOTE 4: INCOME TAXES
The Company, as a Canadian corporation, does not file United States income tax
returns.
Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. The only component of
deferred taxes for the Company is its net operating loss carry forwards of
approximately $13,725,195 in Canada which began to expire in 1997 and $nil in
the U.K. Deferred tax assets at March 31, are:
2007 2006
------------- -------------
Deferred tax assets $ 5,215,574 $ 5,068,561
Valuation allowance (5,215,574) (5,068,561)
----------- -----------
Net deferred-tax asset $ - $ -
=========== ===========
The valuation allowance was increased by $147,013 and $155,246 during the fiscal
years ended March 31, 2007 and 2006, respectively. Given the loss making
position of the Company, it is uncertain whether losses could be utilized in the
foreseeable future and therefore no benefit for deferred tax has been taken.
NOTE 5: STOCKHOLDERS' EQUITY.
There were no options outstanding at the end of fiscal year 2007. No common
stock was issued for cash in fiscal years 2007 or 2006.
NOTE 6: GOING CONCERN
The Company is in default of covenants and repayment schedules on the Term Loan,
Revolving Credit and Credit Accommodations with Wells Fargo Business Credit,
Inc. Interest is being accrued on this debt at the rate of $911.46 per day.
The financial statements have been prepared on the basis that the company is a
"going concern". In the absence of any debt forgiveness from Wells Fargo the
Company cannot pay its debts and is not a "going concern". However the Directors
of the Company do not believe that any material adjustments to the values of
assets or liabilities would be necessary to reflect the "liquidation basis".
The Directors are of the opinion that the Company can become a going concern
again in the future but hinges this opinion on the willingness of the loan
creditor, Wells Fargo, to grant debt forgiveness. It would become a going
concern by incorporating other business activities into the Group. There is no
current intention to place the Company into liquidation.
F-10
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
August 29, 2007 STELAX INDUSTRIES, LTD.
/s/ Harmon S. Hardy, Jr.
-------------------------
By: Harmon S. Hardy, Jr.
President and Chief Financial Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following person on behalf of the registrant and
in the capacities indicated, on August 29, 2007.
NAME OFFICE
/s/ Harmon S. Hardy, Jr. President and Chief Financial Officer
----------------------------------
Harmon S. Hardy, Jr.
(Principal Executive and Financial Officer)